Abstract-The problem of controlling the level of depth of anesthesia measured by the Bispectral Index (BIS) of the electroencephalogram of patients under general anesthesia, is considered. It is assumed that the manipulated variable is the infusion rate of the hypnotic drug propofol, while the drug remifentanil is also administered for analgesia. Since these two drugs interact, the administration rate of remifentanil is considered as an accessible disturbance in combination with the level of electromyography (EMG) that also interferes with the BIS signal. In order to tackle the high uncertainty present on the system, the predictive adaptive controller MUSMAR is used. The performance of the controller is illustrated by means of simulation with 45 patient individual adjusted models, which incorporate the effect of the drugs interaction on BIS. This controller structure proved to be robust to the EMG and remifentanil disturbances, patient variability, changing reference values and noise.
I. INTRODUCTION
Automatic control is playing an increasing role in biomedical applications in a diversity of fields [1] . General anesthesia of patients undergoing surgery comprises three main components: Areflexia, Analgesia and Hypnosis (depth of anesthesia). Areflexia (lack of movement) aims at driving the body to an adequate level of paralysis. Analgesia prevents pain and the phenomena associated to it, e. g. the increase of heart rate. It is achieved through the administration of opioid drugs such as remifentanil. There is no direct sensor providing a unique index of the level of analgesia. Hypnosis (depth of anesthesia) is defined by the degree of unconsciousness. The bispectral index (BIS) of the electroencephalogram (EEG) is a numerical processed, clinically-validated EEG parameter, used as an indicator of the level of hypnosis. The BIS is a number between 0 and 100, where values near 100 represent an "awake" clinical state while 0 denotes the maximal EEG effect possible (i.e., an isoelectric EEG). During surgery, the level of hypnosis should be driven to a value between 40-60 and maintained there. Anesthesia is a complex process, in part due to drug interactions. Indeed, it is known that remifentanil (analgesic) and propofol (hypnotic) potentiate their effects when applied together. This means that, when modeling the level hypnosis (BIS) one has to take into consideration not only the propofol dose but also the dose of remifentanil being administered. The electromyography (EMG), mostly related to muscle activity, is also captured by the EEG monitor and interferes with the BIS level. A high level of EMG can mean patient arousal due to surgical stimulus or lack of muscle relaxation. In what concerns control, this means that, if the degree of unconsciousness is controlled by selecting the dose of propofol (manipulated variable), the dose of remifentanil being administered and the EMG level being recorded may be considered as accessible disturbances and its knowledge may be used to increase the controller's performance. This paper presents a feasibility study of the control of the BIS exploring the above ideas. A simulation study of the control of BIS taking the dose of propofol as manipulated variable, and the remifentanil dose and EMG level as accessible disturbances is presented. In order to tackle the high uncertainty present on the system, the predictive adaptive controller MUSMAR [2] is used. Simulations are performed on a multivariable nonlinear model relating BIS with the doses of propofol and remifentanil published previously [3] . The BIS model is presented in section II, including the pharmacokinetic and pharmacodynamic structure. Section III describes the structure of the adaptive controller. Section IV presents the results of the simulations under different conditions. The conclusions are presented in section V.
II. BISPECTRAL INDEX (BIS) MODEL
The clinical data of 45 neurosurgeries were used in a previous study [3] to test the model structure. The model parameters were adjusted to the individual patients during the first 15 minutes of induction of anesthesia, and used to predict the BIS signal during surgery. The model results were validated for the 45 cases, using the real propofol and remifentanil doses (ml/h). Fig. 1 shows the real propofol and remifentanil doses (ml/h), and BIS and EMG signals for Patient 6 as an example. The maximum rate allowed by the syringe pumps is 1200 ml/h. The objective was to describe the relationship between the drugs effect concentrations and its effect [3] . The pharmacokinetic/pharmacodynamic (PKD) models of the two drugs use a 3-compartment model structure. For propofol, the PKD parameters from Marsh [4] were used, whereas for remifentanil the parameters from Minto [5] were used. Bruhn et al. [6] presented an interaction model structure to relate the EEG parameter values (including BIS) to the effect concentrations of propofol (Ce p (t) µg/ml) and remifentanil (Ce r (t) ng/ml) . First, the effect concentrations were normalized to their respective potencies (EC 50p and EC 50r ), i.e. the effect concentration at half the maximal effect:
The potency of the drug mixture depending on the ratio of the interacting drugs is modeled as (2) .
By definition, θ ranges from 0 (remifentanil only) to 1 (propofol only). The concentration-response relationship for any ratio of the two drugs can be described as (3) .
where BIS 0 is the effect at zero concentrations (e.g. BIS 0 = 97.7 for the case of BIS -monitor restriction), γ is the steepness of the concentration-response relation, and U 50(θ ) is the number of units (U) associated with 50% of maximum effect at ratio θ .
III. THE ADAPTIVE CONTROL ALGORITHM Fig. 2 shows the control system structure: the remifentanil dose and the EMG level are accessible disturbances (v(t)), the propofol dose is the controller output (u(t)), the BIS signal is the controller input (y(t)). The algorithm used is the predictive adaptive controller MUSMAR [2] that aims at minimizing a quadratic cost: 1. Sample plant output, y(t) and compute the tracking error y, with respect to the desired set-point re f (t), by:
2. Using Recursive Least Squares, update the estimates of the parameters θ j , ψ j , µ j−1 and φ j−1 in the following sets Block diagram of the control system structure: the dose of remifentanil dose remi (t) is the real dose used for the identified patient, the real electromyography level EMG (accessible disturbances -v(t)), the dose of propofol dose prop (t) is obtained from the MUSMAR controller (controller output -u(t)), the Bispectral Index BIS(t) signal is the patient model output (controller input -y(t)), and re f (t) is the reference target for BIS.
of predictive models ( j = 1, . . . , T ):
where ≈ denotes equality in least squares sense and s(t) the pseudo-state, given by
with v(t) as the accessible disturbance, and u(t) as the controller output [2] . Since, at time t,ỹ(t + j) and u(t + j) are not available for j ≥ 1, for the purpose of estimating the parameters, the variables in (5) are delayed in block of T samples.
3. Apply to the plant the control given by
where η is a white dither noise of small amplitude and f is the vector of controller gains, computed from the estimates of the predictive models by
where ρ is a positive weight on the control action and α is the normalization factor. The choice of the variables and the number of their past samples entering s(t) defines the structure of the controller. The pseudo state s(t) includes samples of the accessible disturbances to embody feedforward action.
IV. RESULTS
A number of simulations [7] , with a specific patient model (representing patient 23) have been conducted in order to find the best configuration defined by the MUSMAR parameters T , n a , n b and n g with a sampling interval of 5s (the one used for real data collection) without the use of disturbances and considering a constant analgesic concentration. This lead to the choice of T = 5, n a = 9, n b = 10, n g = 1, ρ = 0.0001, σ η = 0.02. The controller gains obtained using the model of Patient 23 (without the accessible disturbances and constant analgesia) were used as the initial gains for all simulations. But this time, the analgesic level was the real dose used for each patient during surgery. The aim was to compare if the use of the real EMG (per patient) in combination with the remifentanil dose, as the accessible disturbances would improve the controllers performance.The cost function J k was calculated for each simulation (k = 1, . . . , 45) after the initial 5min (9) .
In addition, gaussian noise (zero mean and variance 3) was added to the model output (BIS) before the feedback to the MUSMAR controller. The minimum value of J was 2.2 for patient model 23, followed by patient model 43 and 35 both with a J value of 2.4. Fig. 3 shows the BIS versus target reference, the propofol dose (dose prop (t) -controller output) and the MUSMAR controller gains (8) for the simulations with patient model 10 which had a J value of 3. With patient model 6 (Fig. 4 ) a J value of 4.1 and a bigger undershoot in the beginning were obtained. In addition there was a big remifentanil bolus before 4000s which would make the BIS signal decrease (see Fig. 1 ), and the controller is able to respond adequately to the effects of this external disturbance. The controller adequately adjusts its gains to cope with the patient's intervariability. To further evaluate the performance of the MUSMAR controller, the target BIS reference value was changed so as to test the controller performance. Fig. 5 hows the BIS signal for the simulation with patient model 22 (initial J value of 8.5) and 39 (initial J value of 3.3), considering a changing reference value. The controller was able to adequately respond to the changes in reference value in both cases, considering higher or lower references (increasing of decreasing the desired BIS level). Comparing the controller performance with and without the use of with patient model 14 the controller was not able to track the reference, with very poor results (the maximum J value, more than 10 times the second worse). The performance with patient model 14 was always poor, with or without the accessible disturbance and with or without noise.
V. CONCLUSIONS AND FUTURE WORKS

A. Conclusions
This control structure (MUSMAR) proved to be efficient to control the BIS value using the dose of the anesthetic propofol, in extensive simulations using individual patient models adjusted to real clinical data. The fact that the controller gains can follow changing reference values, respond to the EMG interference, and adapt to the individual patient intervariability and remifentanil dose, shows the robustness of the overall structure. The control structure was also robust to the addition of noise in the BIS signal. This is an important aspect, since in the real clinical data setup noise is present in all signals and a robust controller is necessary. Although the gains were initialized with values adjusted to a specific patient with a reference value of 50, the controller adjusted well to different reference values and different patients. In the simulation with patient model 22 and 39, there was a decreased to 40 for the desired BIS value, corresponding to deeper stages of anesthesia required for special surgeries such as aneurysms. While the reference value of 60 corresponds to a smooth and progressive recovery or a level of sedation. These results show that such a control structure could be adequate to control the BIS signal, during total intravenous anesthesia with a combination of two drugs. Previous work [8] showed that the use of EMG improved the controller performance in most models. However, while the analgesic level is used in the patient simulation model, the EMG is not incorporated in the model. Nevertheless, the EMG is a clear clinical disturbance to the BIS value and such fact has been reported [9] . It is important, not just that the patient model incorporates the remifentanil effect, but also that the controller is robust to such interaction and changes the propofol dose accordingly. The use of EMG and remifentanil dose as accessible disturbances improved the controller's performance when comparing to the results without disturbances, but also to the results of only using EMG ( [8] ) or only using remifentanil ( [7] ) with a lower average J value. A key feature in the control of anesthesia is to achieve a good rejection of disturbances. The practitioner knows what the surgeon is doing, as well as his own actions, and is therefore able to anticipate the corresponding induced disturbances, acting to counteract them even before their effects are visible. A major challenge for the automation of anesthesia consists in replicating similar performances. Clearly, this calls for the use of feedforward from measurable signals correlated with disturbances.
B. Future Works
If EMG reflects the lack of muscle relaxation or patient perception is still a question under debate [10] . But an indicator of patient perception of pain/recovery is important when considering control systems for anesthesia. An indicator of the level of nociception (i.e. pain perception), would be an important step for multivariable control in anesthesia. EMG and BIS variability may carry relevant information, and this may be incorporated in a control system but also in a patient model for analgesia. In addition, the research on BIS modeling suggests that there are different groups of patients with respect to the drugs' reaction and model parameters. Therefore, clustering techniques could be used to identify different groups of patients and this used to establish different structures for the controller. The MUSMAR presented in this work had its parameters structure adjusted to one patient model, this could mean that, e. g. patient 14 may need a different structure for the controller.
